Fulcrum Therapeutics Inc share price logo

Fulcrum Therapeutics Inc Share Price

NASDAQ: FULC

Small Cap

$7.32

+0.02

(+0.21%)

as on

Fulcrum Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $7.2
    $7.47
    downward going graph

    1.64%

    Downside

    2.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.32
    $8.5
    downward going graph

    68.37%

    Downside

    16.12%

    Upside

    downward going graph

Fulcrum Therapeutics Inc share price movements today

Previous Close
$7.30
Open
$7.38
Volume
333.8K
Day's Low - High
$7.2 - $7.47
52 Week Low - High
$2.32 - $8.5

Fulcrum Therapeutics Inc Historical Returns

1 Month Return
+ 3.67 %
3 Month Return
+ 9.95 %
1 Year Return
+ 102.58 %
3 Year Return
-20.02 %
5 Year Return
-16.13 %

Fulcrum Therapeutics Inc Stock Fundamentals & Key Indicators

Check Fulcrum Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$394.9M

EPS (TTM)

-1.1438

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-26.95

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

0

EBITDA

-81.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

85283800.00%

Fulcrum Therapeutics Inc Stock Valuation

Track how Fulcrum Therapeutics Inc P/E has moved over time to understand its valuation trends.

Fulcrum Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Today (-26.95x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -26.95x

Fulcrum Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fulcrum Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$394.9M-16.13%-26.950.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Fulcrum Therapeutics Inc Stock including INR - Dollar returns

The Fulcrum Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Fulcrum Therapeutics Inc investment value today

Current value as on today

₹2,14,340

Returns

₹1,14,340

(+114.34%)

Returns from Fulcrum Therapeutics Inc Stock

₹1,09,742 (+109.74%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Fulcrum Therapeutics Inc Stock

Based on 14 analysts

BUY

78.57%

Buy

14.29%

Hold

7.14%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Fulcrum Therapeutics Inc. Average target price of $11.07

Fulcrum Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Fulcrum Therapeutics Inc.

What analysts predicted

33.88%UPSIDE

Target Price

$11.07

Current Price

$7.32

Analyzed by

14 Analysts

Target

$11.07

Fulcrum Therapeutics Inc target price $11.07, a slight upside of 33.88% compared to current price of $7.32. According to 14 analysts rating.

Fulcrum Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Fulcrum Therapeutics Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Fulcrum Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
-
80
-
-
-
-
Gross Profit
0
0
0
0
0
62
-
-
-
-
Operating Income
-27
-27
-27
-27
-29
52
-25
-19
-20
-19
EBITDA
-27
-26
-26
-27
-29
55
-22
-19
-20
-19
Interest Expense
3
-
-
3
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-23
-24
-24
-26
55
-21
-16
-17
-17
Income Tax Expense
-3
0
0
3
0
-
-
-
-
-
Net Income
-21
-23
-24
-24
-26
55
-21
-16
-17
-17
Net Profit Margin
-7328.14%
-2702.61%
-3164.30%
-2842.25%
0.00%
69.26%
0.00%
0.00%
0.00%
0.00%

Fulcrum Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
0
8
19
6
2
80
Gross Profit
0
-1
-2
8
19
3
2
78
Operating Income
-22
-33
-84
-71
-81
-112
-110
-21
EBITDA
-22
-32
-82
-69
-78
-109
-108
-18
Interest Expense
-
-
-
-
2
2
-
-
Depreciation
0
1
2
2
2
2
2
1
Income Before Tax
-22
-32
-82
-70
-80
-109
-97
-9
Income Tax Expense
0
0
-3
-2
-2
-4
2
-
Net Income
-22
-32
-79
-68
-78
-105
-97
-9
Net Profit Margin
0.00%
0.00%
-10548.40%
-775.70%
-408.77%
-1665.42%
-3470.05%
-12.16%

Fulcrum Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-23
-24
-24
-26
55
-21
-16
-17
-17
Operating Cash Flow
-20
-22
-23
-25
58
-19
-16
-15
-13
Investing Cash Flow
19
19
18
38
-12
4
2
0
13
Financing Cash Flow
0
117
0
1
0
0
0
-
0
Change in Cash
0
-3
-4
14
46
-14
-14
-16
0

Fulcrum Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-32
-82
-70
-80
-109
-97
-9
Operating Cash Flow
-22
-39
-53
-78
-97
-90
-2
Investing Cash Flow
-8
0
-57
-129
12
-36
32
Financing Cash Flow
105
64
71
186
84
118
2
Change in Cash
73
23
-39
-21
0
-9
32

Global Institutional Holdings in Fulcrum Therapeutics Inc

Funds
Holdings
RA Capital Management, LLC
18.91%
TCG Crossover Management, LLC
9.71%
Suvretta Capital Management, LLC
9.37%
Nantahala Capital Management, LLC
8.92%
BlackRock Inc
8.71%

Insights on Fulcrum Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, FULC stock has moved up by 141.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 759.0K → 80.0M (in $), with an average increase of 55.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, FULC has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -17.65M → -17.29M (in $), with an average increase of 2.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 133.9%

About Fulcrum Therapeutics Inc

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng
OrganisationFulcrum Therapeutics Inc
Headquarters26 Landsdowne Street, Cambridge, MA, United States, 02139
IndustryHealth Technology
CEOMr. Alexander C. Sapir
E-voting on sharesClick here to vote

Key Management of Fulcrum Therapeutics Inc

Name

Title

Mr. Alexander C. Sapir

CEO, President & Director

Dr. Bradley E. Bernstein M.D., Ph.D.

Founder

Dr. Michael R. Green

Founder

Dr. Rudolf Jaenisch M.D., Ph.D.

Founder

Dr. Tsun-Huei Lee M.D., Ph.D.

Founder

Dr. Danny Reinberg

Founder

Dr. Jeffrey W. Jacobs Ph.D.

Chief Scientific Officer

Mr. Alan A. Musso C.M.A., CPA

Chief Financial Officer

Mr. Curtis G. Oltmans J.D.

Senior VP, Chief Legal Officer & Corporate Secretary

Mr. Gregory Tourangeau

Controller & Principal Accounting Officer

FAQs

What is Fulcrum Therapeutics Inc share price today?

Fulcrum Therapeutics Inc share price today is $7.32 as on at the close of the market. Fulcrum Therapeutics Inc share today touched a day high of $7.47 and a low of $7.2.

What is the 52 week high and 52 week low for Fulcrum Therapeutics Inc share?

Fulcrum Therapeutics Inc share touched a 52 week high of $8.5 on and a 52 week low of $2.32 on . Fulcrum Therapeutics Inc stock price today i.e. is closed at $7.32,which is 13.88% down from its 52 week high and 216.20% up from its 52 week low.

What is Fulcrum Therapeutics Inc's market capitalisation today?

Fulcrum Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Fulcrum Therapeutics Inc Stock (FULC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Fulcrum Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fulcrum Therapeutics Inc Shares that will get you 0.2049 shares as per Fulcrum Therapeutics Inc share price of $7.32 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Fulcrum Therapeutics Inc Stock (FULC) from India?

Indian investors can start investing in Fulcrum Therapeutics Inc (FULC) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Fulcrum Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Fulcrum Therapeutics Inc share’s latest price of $7.32 as on September 18, 2025 at 1:29 am IST, you will get 1.3661 shares of Fulcrum Therapeutics Inc. Learn more about fractional shares .

What are the returns that Fulcrum Therapeutics Inc has given to Indian investors in the last 5 years?

Fulcrum Therapeutics Inc stock has given -16.13% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?